Preliminary results of early clinical trials with the fully human anti-TNFalpha monoclonal antibody D2E7.
Kempeni
J
J
Department of Clinical Oncology/Immunology, Knoll AG-BASF Pharma, Knollstrasse, D-67008 Ludwigshafen, Germany.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha